Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 1
2015 1
2016 3
2017 1
2018 2
2019 4
2020 6
2021 8
2022 7
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Spreading depolarization suppression from inter-astrocytic gap junction blockade assessed with multimodal imaging and a novel wavefront detection scheme.
Ringuette D, EbrahimAmini A, Sangphosuk W, Aquilino MS, Carroll G, Ashley M, Bazzigaluppi P, Dufour S, Droguerre M, Stefanovic B, Levi O, Charveriat M, Monnier PP, Carlen PL. Ringuette D, et al. Among authors: charveriat m. Neurotherapeutics. 2024 Jan;21(1):e00298. doi: 10.1016/j.neurot.2023.10.008. Epub 2023 Dec 19. Neurotherapeutics. 2024. PMID: 38241157 Free PMC article.
Pharmaco-fUS in cognitive impairment: Lessons from a preclinical model.
Vidal B, Pereira M, Valdebenito M, Vidal L, Mouthon F, Zimmer L, Charvériat M, Droguerre M. Vidal B, et al. Among authors: charveriat m. J Psychopharmacol. 2022 Nov;36(11):1273-1279. doi: 10.1177/02698811221128963. Epub 2022 Oct 7. J Psychopharmacol. 2022. PMID: 36205074
Impact of Donepezil on Brain Glucose Metabolism Assessed Using [18F]2-Fluoro-2-deoxy-D-Glucose Positron Emission Tomography Imaging in a Mouse Model of Alzheimer's Disease Induced by Intracerebroventricular Injection of Amyloid-Beta Peptide.
Hugon G, Goutal S, Sarazin M, Bottlaender M, Caillé F, Droguerre M, Charvériat M, Winkeler A, Tournier N. Hugon G, et al. Among authors: charveriat m. Front Neurosci. 2022 Feb 25;16:835577. doi: 10.3389/fnins.2022.835577. eCollection 2022. Front Neurosci. 2022. PMID: 35281502 Free PMC article.
Clinical pharmacology: Current innovations and future challenges.
Cracowski JL, Hulot JS, Laporte S, Charvériat M, Roustit M, Deplanque D, Girodet PO; French Society of Pharmacology and Therapeutics (SFPT). Cracowski JL, et al. Among authors: charveriat m. Fundam Clin Pharmacol. 2022 Jun;36(3):456-467. doi: 10.1111/fcp.12747. Epub 2022 Jan 26. Fundam Clin Pharmacol. 2022. PMID: 34954839 Review.
Use of real-world evidence in translational pharmacology research.
Charvériat M, Darmoni SJ, Lafon V, Moore N, Bordet R, Veys J, Mouthon F; SFPT Translational Research in Pharmacology group. Charvériat M, et al. Fundam Clin Pharmacol. 2022 Apr;36(2):230-236. doi: 10.1111/fcp.12734. Epub 2021 Nov 2. Fundam Clin Pharmacol. 2022. PMID: 34676579 Review.
29 results